Condition
Hypervitaminosis A
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Vitamin A Supplement
Research Leaders
8 sponsors active, led by International Atomic Energy Agency
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Vitamin A Supplement1
Active Sponsors
- International Atomic Energy Agency1
- Medical Research Council, South Africa1
- INACIF1
- Bill and Melinda Gates Foundation1
- Newcastle University1
Top Investigators
Newcastle University
Institute of Nutrition of Central America and Panama
HarvestPlus
Medical Research Council, South Africa
Medical Research Council, South Africa
Related Conditions
- Vitamin A Toxicity1
- Vitamin A Deficiency1